JEREMY B. HAYDEN
CIK 1650737 · Chief Legal Officer · last filed 2026-04-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.90M
Companies
3
Total Filings
34
Lifetime Open-Market Net
-$798.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SGHT | Chief Legal Officer | 369,770 | $5.13 | $1.90M | -$808.3K | 22 | 2026-04-09 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | General Counsel | 32,040 | — | — | $0 | 5 | 2019-10-07 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | General Counsel & VP of BD | 3,643 | — | — | $10.0K | 7 | 2017-03-17 |
Recent Filings · Page 4 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-01-04 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-09-03 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Buy (P) | +8,200 | $2.9K | EDGAR |
| 2015-08-21 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Buy (P) | +18,000 | $7.1K | EDGAR |
| 2015-08-12 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–34 of 34
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.